A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
Reference:
NPJ Vaccines. 2021 Apr 1;6(1):46
Malaria continues to be a pressing global health issue, causing nearly half a million deaths per year. An effective malaria vaccine could radically improve our ability to control and eliminate this pathogen. The most advanced malaria vaccine, RTS,S, confers only 30% protective efficacy under field conditions, and hence the search continues for improved vaccines.
